T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
20/10/26	KRW 2,020.00	-2.65%	89,149
19/10/26	KRW 2,075.00	+2.22%	109,978
16/10/26	KRW 2,030.00	+4.26%	103,221
15/10/26	KRW 1,947.00	-5.02%	276,888
14/10/26	KRW 2,050.00	0.00%	106,945

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 20/10/2026			5-day change	1st Jan Change
2,020.00 ^KRW	-2.65%		-1.46%	-48.34%

21/01	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	96.27B 72.5M 64.53M 59.81M 54.2M 102M 6.87B 104M 718M 282M 3.59B 272M 266M 11.47B	P/E 2024	-12.2x	P/E 2025	-3.91x
Enterprise Value	118B 88.84M 79.08M 73.29M 66.41M 125M 8.42B 127M 879M 345M 4.4B 333M 326M 14.05B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	85.08%	Yield 2024 *	-	Yield 2025	-

21/01	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
05/08/24	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
23/07/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
04/07/24	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
25/06/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
22/12/23	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
14/12/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
19/10/23	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
04/08/23	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
26/07/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
15/05/23	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
20/09/21	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	-2.65%
1 week	-1.46%
Current month	-5.16%
1 month	-11.21%
3 months	-2.42%
6 months	-38.04%
Current year	-48.34%

T&R Biofab Co., Ltd. Stock

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news: T&R Biofab Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

1 week	1,918	2,115
1 month	1,918	2,380
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	9,250
5 years	1,127	29,625
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	57	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/3/25	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
6/3/25	Eun-kyung Cho	Others		15,492	0.0719%
26/2/25	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	-2.65%	-1.46%	+15.70%	-75.37%	72.5M
ABBOTT LABORATORIES	-1.55%	-0.16%	-20.89%	+5.86%	177B
STRYKER CORPORATION	+2.17%	+7.73%	-20.15%	+14.57%	117B
MEDTRONIC PLC	+2.00%	+1.74%	-1.34%	+30.17%	116B
ESSILORLUXOTTICA	-1.02%	+2.87%	-52.05%	-7.70%	77.71B
CENCORA, INC.	+0.96%	+3.99%	+4.85%	+81.86%	65.51B
HOYA CORPORATION	+2.46%	+4.84%	+16.19%	+83.66%	54.97B
BECTON, DICKINSON AND COMPANY	+1.60%	+3.43%	+1.47%	-25.07%	52.79B
IDEXX LABORATORIES, INC.	+0.38%	+7.23%	-13.29%	+30.66%	43.95B
DEXCOM, INC.	-0.28%	+0.80%	+25.30%	-0.27%	32.35B
Average	+0.41%	+2.89%	-4.42%	+13.84%	73.72B
Weighted average by Cap.	+0.57%	+3.04%	-11.85%	+21.17%

	2024	2025
Net sales	4.87B 3.67M 3.27M 3.03M 2.74M 5.16M 348M 5.24M 36.33M 14.27M 182M 13.77M 13.48M 580M	26.97B 20.31M 18.08M 16.75M 15.18M 28.53M 1.92B 29.01M 201M 78.97M 1.01B 76.17M 74.59M 3.21B
Net income	-7.68B -5.78M -5.15M -4.77M -4.32M -8.12M -548M -8.26M -57.24M -22.49M -287M -21.69M -21.24M -915M	-31.95B -24.06M -21.42M -19.85M -17.99M -33.8M -2.28B -34.37M -238M -93.56M -1.19B -90.25M -88.38M -3.81B
Net Debt	28.78B 21.67M 19.29M 17.88M 16.2M 30.45M 2.05B 30.96M 215M 84.28M 1.07B 81.3M 79.61M 3.43B	21.7B 16.34M 14.55M 13.48M 12.22M 22.96M 1.55B 23.34M 162M 63.55M 810M 61.3M 60.03M 2.58B